AstraZeneca’s Andexxa Could Be Headed For Withdrawal After US FDA’s Negative Advisory Committee Preview
The confirmatory trial for the anticoagulant reversal agent raised safety and efficacy concerns from the agency.
The confirmatory trial for the anticoagulant reversal agent raised safety and efficacy concerns from the agency.